Papers
2
Total Citations
66
H-Index
2
About
Sen Zhong is a leading clinical researcher in gynecologic oncology, with a primary focus on optimizing surgical treatments for early-stage cervical cancer. Her major contributions center on rigorously evaluating the efficacy and safety of minimally invasive surgery (MIS) versus open approaches. She is the lead author of a pivotal phase III multicenter randomized controlled trial in China (2019), which directly addresses the controversial findings of the LACC trial by comparing different surgical approaches for early-stage cervical cancer—a study that has garnered 56 citations for its critical impact on clinical practice. Additionally, her work on a protocol comparing minimally invasive radical trachelectomy (MIRT) to abdominal radical trachelectomy (ART) (2020, 10 citations) explores fertility-sparing options, highlighting her commitment to improving both oncologic and reproductive outcomes for young patients. Through these high-impact, practice-shaping trials, Dr. Zhong is at the forefront of evidence-based surgical decision-making in cervical cancer, providing crucial data that helps surgeons and patients navigate the complex trade-offs between survival, quality of life, and fertility preservation.
Research Focus
Key Achievements
Top Papers
- 1
- 2